The dynamics of drug resistance in Plasmodium falciparum.
about
Challenges of drug-resistant malariaA mechanism for the synergistic antimalarial action of atovaquone and proguanilIn vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparumAssociation of house spraying with suppressed levels of drug resistance in ZimbabweHow sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapyMolecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapyFrequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, YemenEnhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitisPatterns and predictors of self-medication in northern UgandaGlobal change and human vulnerability to vector-borne diseasesSpatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum.Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in IndiaMolecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon.Expanding the Antimalarial Drug Arsenal-Now, But How?Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.Differential genetic hitchhiking around mutant pfcrt alleles in the Indian Plasmodium falciparum population.Effects of mefloquine use on Plasmodium vivax multidrug resistanceEmerging artemisinin resistance in the border areas of Thailand.High efficacy of short-term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic.History, dynamics, and public health importance of malaria parasite resistance.Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.Cost-saving through microscopy-based versus presumptive diagnosis of malaria in adult outpatients in Malawi.Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.Variation in infection length and superinfection enhance selection efficiency in the human malaria parasite.Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.Genetics of chloroquine-resistant malaria: a haplotypic view.Prolonged parasite clearance in a Chinese splenectomized patient with falciparum malaria imported from Nigeria.Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance.History and importance of antimalarial drug resistance.Pharmacodynamic interaction between mefloquine and retinol in Plasmodium falciparum in vitro.Pharmacodynamic interaction of doxycycline and artemisinin in Plasmodium falciparum.Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component.Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro.Development and evaluation of anti-malarial bio-conjugates: artesunate-loaded nanoerythrosomes.The threat of antimalarial drug resistance.
P2860
Q21032482-088824EF-0D14-47CE-8F40-E90493616D01Q24550657-5CF45E4E-309D-4080-B7D3-08C406360D4BQ24679711-365417DF-F400-4104-B17E-7D127DBB8B2DQ24803104-CA745F50-00EB-495B-83D6-04402078A118Q25255530-FD0FEF19-1FE4-4C83-B67F-BA2A5ED93EF2Q28125911-3840D2A2-7FCC-4F3C-8D74-122A02D732B7Q28125931-6762B91F-3D3F-49B0-B655-5C7E1C9FD785Q28379521-7C174BC3-F5E9-4B47-9633-EBE36EB14141Q28541309-B73388CE-AC9A-4E9E-9491-A0E02133D508Q28776363-86009E10-FB7F-4E65-A396-9E68D872D427Q30541962-F9AF8A19-EAA8-44E5-AF14-D3FD6B6D0BD9Q33676392-CE4CB540-8C78-41C9-8A36-15AB22DED016Q33694419-BF841934-6C97-4733-836D-9229A1593A1AQ33696891-781D8E9E-CD17-4DD6-895D-88BB6ABD81AEQ33916111-EE8018D0-D591-49DD-B760-2EC5FAD0E171Q33968854-91FEA7FA-F77D-4BD5-9E20-D7EEA1569024Q34114241-0342E1F5-1498-4AB1-B925-3E39FED41E5CQ34320936-8F06EDF8-F055-40F9-BEC1-FF34B135C584Q34343530-E2844690-79FA-4471-ABAF-8D11AD78A492Q35111216-92FDD9F9-966E-4C0A-854C-23B8D0A651D7Q35545447-EEF050EC-BB9B-42F3-BC0A-FB2C01918EEFQ35859975-CFEBC811-D78F-495F-B207-41AA5F3F475CQ36671618-B37BD749-3852-4CFD-A1AE-091482D6C114Q36702998-4920E5EA-1E19-4FD9-814A-EBF125772AB6Q36794794-CEE43DAE-150A-4B46-9D14-5A930607AA29Q36886893-348B938D-B90A-408C-A66E-A5A0DCA65CF3Q36914971-EB198AEF-AA38-4C08-BC4B-AEF974284A32Q37278622-B3001160-1A9F-4E7E-9FF9-2BE4DDC47AACQ37390583-613A79F9-D34F-4646-97C2-BFB67487A66DQ37734142-6C9E31C7-F2EA-41D8-9818-4A043F7EAE24Q37736719-519FEE10-C9E5-4EAD-A229-FF3AED068109Q38127840-09A7C4B0-FBC0-44B0-B54C-EC0C35CD0BAEQ38959049-6A6CFD77-3B15-41B3-AC28-1E3C489B50A2Q39034428-24570813-CB6D-4A99-8BFD-7C2A74DA5C6EQ39483548-1634FDD8-FFE5-447C-95F0-CC9B26D891E8Q39557015-F74B257D-F613-4F34-86C9-A5937E667039Q39782956-3BD3C921-CE67-470A-953C-DDA080F8A7B5Q40291075-631576A2-8E49-4A80-9F11-15D4670B6153Q40681213-6E658B76-C8D0-4CC8-A91F-938B04F252ABQ41149881-3F84E592-5B40-4113-A126-A5FE2EFB5AB3
P2860
The dynamics of drug resistance in Plasmodium falciparum.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The dynamics of drug resistance in Plasmodium falciparum.
@en
The dynamics of drug resistance in Plasmodium falciparum.
@nl
type
label
The dynamics of drug resistance in Plasmodium falciparum.
@en
The dynamics of drug resistance in Plasmodium falciparum.
@nl
prefLabel
The dynamics of drug resistance in Plasmodium falciparum.
@en
The dynamics of drug resistance in Plasmodium falciparum.
@nl
P1476
The dynamics of drug resistance in Plasmodium falciparum.
@en
P2093
Wernsdorfer WH
P304
P356
10.1016/0163-7258(91)90074-V
P577
1991-01-01T00:00:00Z